SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-191942
Filing Date
2023-07-24
Accepted
2023-07-24 09:12:58
Documents
18
Period of Report
2023-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d527822d8k.htm   iXBRL 8-K 36160
2 EX-10.1 d527822dex101.htm EX-10.1 366914
3 EX-10.2 d527822dex102.htm EX-10.2 12842
4 EX-99.1 d527822dex991.htm EX-99.1 8361
5 EX-99.2 d527822dex992.htm EX-99.2 9120
9 GRAPHIC g527822g0723000747951.jpg GRAPHIC 2821
10 GRAPHIC g527822g0723000758188.jpg GRAPHIC 2807
  Complete submission text file 0001193125-23-191942.txt   680652

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20230721.xsd EX-101.SCH 2850
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20230721_lab.xml EX-101.LAB 17994
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20230721_pre.xml EX-101.PRE 11261
12 EXTRACTED XBRL INSTANCE DOCUMENT d527822d8k_htm.xml XML 3460
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 231103881
SIC: 2834 Pharmaceutical Preparations